Abstract

Breast cancer, a heterogeneous disease with diverse subtypes, remains a leading cause of cancer-related morbidity and mortality among women worldwide. The identification and characterization of various breast cancer subtypes have been pivotal in developing targeted therapies and improving patient outcomes. This comprehensive review examines the major breast cancer subtypes, their associated biomarkers, and the clinical implications of these biomarkers in diagnosis, prognosis, and treatment.